Pharma Companies Are Taking Away Risk Through Spinoffs: Here's Why

David Hsu, Wharton Professor of Management, joins the show to discuss J&amp;J's Biggest IPO since 2021 and why pharmaceutical companies are increasingly spinning off their consumer-focused brands. <br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>